Articles

Life sciences jobs pack 2-for-1 punch

While life sciences companies don’t rack up huge jobs numbers, their relatively high pay means that every job they create is worth two in the rest of the private sector.

Read More

UIndy plans $50M in expansion projects

The bulk of the money, to be spent over five years, will go to a 134,000-square-foot health sciences center, which will provide training space for the university’s nursing, physical therapy and other health care students.

Read More

Anthem seeking OK to test online physician visits

House Bill 1258 would allow the large health insurer Anthem Blue Cross and Blue Shield to launch a pilot program using the Live Health Online technology it has developed with Massachusetts-based software firm American Well Corp.

Read More

Doubt over how to run effective preschools derailed bill

Sen. Luke Kenley scuttled a pilot program of state-funded preschool vouchers for low-income families on Feb. 19, instead sending it to a summer committee to investigate 10 questions he said will help make sure Indiana launches a worthwhile program.

Read More

What happens if Pence, Sebelius can’t make a deal?

Even if Gov. Mike Pence and Obama’s health secretary can’t come to terms this weekend, there are ideas bouncing around the state legislature that suggest other ways Indiana could expand coverage to low-income Hoosiers.

Read More

The weightlessness of Obamacare

Rich employer benefits are not always so attractive, sick patients are not always money losers for insurers, and hospitals and doctors are now health care preventers rather than health care providers. This is the bizarre world to which Obamacare has brought us.

Read More

Generous employer benefits now hurt some workers

Ever since World War 2, when employers started using health benefits to compete for workers, the less employees had to pay toward health insurance premiums the more attractive the benefits. But under Obamacare, this axiom will not always be true.

Read More

Falling reimbursements force Roche to innovate

U.S. sales are plunging for Roche Diagnostics Corp. and its fellow makers of diabetes-care devices because of lower reimbursements from the federal Medicare program. In five years, two of the four largest companies will have sold or closed their diabetes businesses, according to two industry analysts.

Read More